Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

Blank Rome partner <a href="/people/merle-m-delancey/" id="19208">Merle M. DeLancey, Jr.</a> will serve as a presenter for two sessions of <a href="https://www.americanconference.com/drug-pricing/">Rx Drug Pricing &amp; Rebate Fundamentals</a>, an American Conference Institute (“ACI”) Virtual Proficiency Series program being held October 30 through November 29, 2023.

core/paragraph

core/heading

Compendium of State Drug Transparency Laws Wednesday, November 1 3:15–4:20 p.m. EDT

This session will explore the rise of state transparency laws across the country and how they are working in conjunction with government payor programs.

Identifying states with current and pending drug pricing transparency laws

core/list

core/list-item

Addressing challenges with and finding solutions for reporting under non-uniform and sometimes conflicting state laws

Developing a system to keep track of these laws as well as a compliance program to address them

Impact of transparency laws on Medicaid pricing

Advanced VA and DOD Pricing and Contracting Wednesday, November 8 2:30–4:15 p.m. EST

Specialized arrangements for personalized medicines

Reviewing criteria for a drug to be eligible for consideration under the FSS

Analyzing how target drugs are chosen by VA/DoD/IHS/BOP for joint national contract targets

What are the general requirements for issuing a drug contract?

Understanding the factors for creating the requirements in the estimated volume of purchase

What is the process for having the contract for a drug renewed?

Identifying the factors considered by the agencies when a drug is up for renewal

Understanding the differences in the processes used by the VA National Acquisition Center and Defense Logistics Agency

ACI’s Rx Drug Pricing &amp; Rebate Fundamentals is an intensive training program that will give novices and experienced practitioners alike a thorough understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs.

The program is designed to make attendees proficient in essential pricing and rebate concepts under Medicaid, Medicare, and other related government payor programs, including those under the auspices of PHS 340B, the VA, and DoD. The course agenda has been refreshed to include in-depth sessions on changes to the pricing and rebate system under the Inflation Reduction Act as well as proposed changes to the Medicaid Drug Rebate Program under CMS’s newly Proposed Rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.

Sessions will be held Monday and Wednesday afternoons over the course of four weeks and examine:

Drug Pricing and Rebate Essentials and Introduction to Medicaid

PHS 340 B, VA and DoD Rx Pricing and Rebates

Medicare Pricing and Rebate Essentials and Advanced CMS Pricing and Rebate Topics

Pricing and Reimbursement for New Products and Therapies

For more information and to register, please visit the&nbsp;<a href="https://www.americanconference.com/drug-pricing/">event webpage</a>.

ACI Rx Drug Pricing & Rebate Fundamentals

Offices

Stay Connected

Slide Menu

Slide Search

ACI Rx Drug Pricing & Rebate Fundamentals

Offices

Stay Connected